Iron uptake in cancer cells is increased through the upregulation of Transferrin/Transferrin-receptor (Tf/TfR), and Lipocalin-2/Lipocalin-2 Receptor (Lcn-2/Lcn-2R) systems and also Divalent Metal Transporter-1 (DMT1) [20,21]. Here, TFRC is linked to cancer.